Regulations.gov document
U.S. Patent and Trademark Office to GlaxoSmithKline
Rule · FDA-2002-E-0120 · posted Apr 23, 2007
Key facts
| Document ID | FDA-2002-E-0120-0006 |
|---|---|
| Title | U.S. Patent and Trademark Office to GlaxoSmithKline |
| Document type | Rule |
| Subtype | CEP-Certificate Extending Patent Term |
| Agency | FDA |
| Docket | FDA-2002-E-0120 |
| Posted | Apr 23, 2007 |
| Effective date | Apr 11, 2007 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: